Govt should roll out comprehensive National Cancer Care Policy with dedicated funding outlay: FICCI-EY Parthenon Report: Our ...

Oversimplification about integration of traditional & modern treatment systems creates confusion: Dr Kotecha: Peethaambaran ...

Oncoinvent announces positive interim results from phase 1/2a studies of Radspherin for treatment of peritoneal carcinomatosis: Oslo, Norway Tuesday, November 12, 2024, 18:00 Hrs ...

Relief Therapeutics announces positive final results of RLF-TD011 trial in epidermolysis bullosa: Geneva Tuesday, November 12, 2024, 10:00 Hrs [IST] Relief Therapeutics Holding SA ...

Chicago, Illinois Tuesday, November 12, 2024, 14:00 Hrs [IST] ...

Tectonic Therapeutic to present positive phase 1a results of TX45, a long-acting, Fc-relaxin fusion protein at AHA 2024: Watertown, Massachusetts Tuesday, November 12, 2024, 13:00 ...

EnteroBiotix Limited, a clinical-stage biotechnology company focussed on developing best-in-class full-spectrum microbiome therapeutics, announced positive results from its phase 1b IMPuLCE study ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, has announced it is pledging $7.8 million to the ‘Fund our Futures’ campaign led by ...

DoP releases operational guidelines for Strengthening of Medical Device Industry scheme: Gireesh Babu, New Delhi Tuesday, November 12, 2024, 08:00 Hrs [IST] The Department of Phar ...

STEERLife, a pioneer in pharmaceutical development technologies, and Callidus Research Laboratories, a formulation development services company with a wealth of experience in comprehensive ...

Healthium and HSSC ink MoU to enhance certification in skill development for Indian healthcare: Our Bureau, Bengaluru Tuesday, November 12, 2024, 12:15 Hrs [IST] Healthium Medtech ...

ALK licenses rights to adrenaline nasal spray, neffy from ARS Pharma for emergency treatment of allergic reactions: Hørsholm, Denmark Tuesday, November 12, 2024, 12:00 Hrs [IST] ...